CT-P6: Clinical Trials

2 trials of CT-P6, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 22Completed 1, Terminated 1

Follow CT-P6: new trials by email Literature Review of CT-P6 trials Research Report on CT-P6

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer
Copanlisib, Pertuzumab, Trastuzumab - Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)22021-05-202025-10-01
Evaluate Safety, Efficacy and Pharmacokinetics
CT-P6, Herceptin, Paclitaxel - Metastatic Breast Cancer
Phase 1 / Phase 2CompletedCelltrion1432010-02-012025-01-24

Conditions studied

Breast Neoplasms (2)

Sponsors

Celltrion (1)  ·  National Cancer Institute (NCI) (1)

Countries

South Korea (1)  ·  United States (1)

Top investigators

Investigational Site (1)  ·  Senthilkumar Damodaran (1)

NIH funding

UM1CA186688 (1)